Effect of the BH3 Mimetic Polyphenol (–)-Gossypol (AT-101) on the in vitro and in vivo Growth of Malignant Mesothelioma
Malignant mesothelioma (MM) is a primary tumor arising from mesothelial cells. The survival of MM patients following traditional chemotherapy is poor, thus innovative treatments for MM are needed. (-)-gossypol (AT-101) is a BH3 mimetic compound which possesses anti-tumoral activity by targeting mult...
Main Authors: | Monica Benvenuto, Rosanna Mattera, Joshua Ismaele Sticca, Piero Rossi, Chiara Cipriani, Maria Gabriella Giganti, Antonio Volpi, Andrea Modesti, Laura Masuelli, Roberto Bei |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-11-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2018.01269/full |
Similar Items
-
AT101 [(-)-Gossypol] Selectively Inhibits MCL1 and Sensitizes Carcinoma to BH3 Mimetics by Inducing and Stabilizing NOXA
by: David J. Mallick, et al.
Published: (2020-08-01) -
Induction of multiple subroutines of regulated necrosis in murine macrophages by natural BH3-mimetic gossypol
by: Zhong Meiyan, et al.
Published: (2021-12-01) -
BH3-mimetics: recent developments in cancer therapy
by: Paul A. Townsend, et al.
Published: (2021-11-01) -
Comparison of putative BH3 mimetics AT-101, HA14-1, sabutoclax and TW-37 with ABT-737 in platelets
by: Hao Wei, et al.
Published: (2021-01-01) -
BH3 Mimetics in Hematologic Malignancies
by: Pavel Klener, et al.
Published: (2021-09-01)